Sara A. Fitzsimmons

Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors

R Rampling, Garth Cruickshank, Alexander D. Lewis et al. · International Journal of Radiation Oncology*Biology*Physics · 1994 · 298 citations

Neuro-oncology, Biochemistry, Malignant Disease +10

Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9

Sara A. Fitzsimmons, Paul Workman, Michael R. Grever et al. · JNCI Journal of the National Cancer Institute · 1996 · 234 citations · Full text

Reduction of 3-amino-l,2,4-benzotriazine-l,4-di-<i>N</i>-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH: cytochrome P450 oxidoreductase

Sara A. Fitzsimmons, Alexander D. Lewis, Robert J. Riley et al. · Carcinogenesis · 1994 · 64 citations

Genetic and functional analyses exclude mortality factor 4 (MORF4) as a keratinocyte senescence gene.

S Bryce, Nicholas R. Forsyth, Sara A. Fitzsimmons et al. · PubMed · 1999 · 12 citations

Aging, Cytogenetics, Genetics +18

Functional evidence for a squamous cell carcinoma mortality gene(s) on human chromosome 4

Nicholas R. Forsyth, Vivienne Morrison, Nicola J. Craig et al. · Oncogene · 2002 · 10 citations

Tumor Biology, Human Chromosome 4, Cytogenetics +10